These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3512954)

  • 41. Significance of acanthosis nigricans in childhood obesity.
    Guran T; Turan S; Akcay T; Bereket A
    J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acanthosis nigricans in obese Chinese children.
    Ng HY; Young JH; Huen KF; Chan LT
    Hong Kong Med J; 2014 Aug; 20(4):290-6. PubMed ID: 24762331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin resistance with acanthosis nigricans and acral hypertrophy.
    Holdaway IM; Frengley PA; Graham FM; Wong M
    N Z Med J; 1984 May; 97(755):286-8. PubMed ID: 6587221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.
    Olefsky JM; Kolterman OG
    Am J Med; 1981 Jan; 70(1):151-68. PubMed ID: 7006388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk.
    Stuart CA; Smith MM; Gilkison CR; Shaheb S; Stahn RM
    Am J Public Health; 1994 Nov; 84(11):1839-42. PubMed ID: 7977931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.
    Atwa M; Emara A; Balata M; Youssef N; Bayoumy N; Sherif A; Fiala L
    Int J Dermatol; 2014 Oct; 53(10):e410-20. PubMed ID: 24168156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of insulin resistance associated with acanthosis nigricans.
    Fukushima N; Matsuura N; Nohara Y; Fujita H; Endo M; Abe K; Kosaka S; Satomi S
    Tohoku J Exp Med; 1984 Oct; 144(2):129-38. PubMed ID: 6393448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect.
    Schwenk WF; Rizza RA; Mandarino LJ; Gerich JE; Hayles AB; Haymond MW
    Diabetes; 1986 Jan; 35(1):33-7. PubMed ID: 3510137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Insulin receptors in syndromes involving acanthosis nigricans and severe insulin resistance].
    Muggeo M; Businaro V; Faronato PP; Moghetti P; Valerio A; Cardin-de' Stefani E; Chieregato GC
    G Ital Dermatol Venereol; 1982; 117(2):73-82. PubMed ID: 6764907
    [No Abstract]   [Full Text] [Related]  

  • 51. Juvenile acanthosis nigricans and insulin resistance.
    Hermanns-Lê T; Hermanns JF; Piérard GE
    Pediatr Dermatol; 2002; 19(1):12-4. PubMed ID: 11860562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action.
    Harrison LC; Dean B; Peluso I; Clark S; Ward G
    J Clin Endocrinol Metab; 1985 May; 60(5):1047-52. PubMed ID: 3884647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and significance of acanthosis nigricans in an adult obese population.
    Hud JA; Cohen JB; Wagner JM; Cruz PD
    Arch Dermatol; 1992 Jul; 128(7):941-4. PubMed ID: 1626961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Insulin resistance with acanthosis nigricans: a case report].
    Fukushima N; Nohara Y; Fujita H; Endo M; Abe K; Matsuura N; Kosaka S; Satomi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Jun; 58(6):807-16. PubMed ID: 6749565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hyperinsulinism syndromes caused by insulin resistance].
    Robert JJ
    Ann Pediatr (Paris); 1990 Mar; 37(3):143-9. PubMed ID: 2190520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
    Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P
    J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism.
    Krishnamurthy M; Pingul MM
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1201-1205. PubMed ID: 27505086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.
    Conway GS; Jacobs HS
    Postgrad Med J; 1990 Jul; 66(777):536-8. PubMed ID: 2217009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.
    Kahn CR; Flier JS; Bar RS; Archer JA; Gorden P; Martin MM; Roth J
    N Engl J Med; 1976 Apr; 294(14):739-45. PubMed ID: 176581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies.
    Kellett HA; Collier A; Taylor R; Sawers JS; Benton C; Doig A; Baird D; Clarke BF
    Metabolism; 1988 Jul; 37(7):656-9. PubMed ID: 3386533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.